High Risk Crack Use Settings and HIV in El Salvador (Encuentro)

May 12, 2021 updated by: Julia Dickson-Gomez, Medical College of Wisconsin
This project will first increase the accessibility and acceptability of rapid HIV testing in health clinics located in or near four low-income communities in San Salvador, El Salvador. The investigators will use crack users' social networks and small incentives, as recommended by the CDC, in collaboration with the Salvadoran Ministry of Public Health and Social Assistance (MSPAS) to encourage crack users to receive HIV testing. The second part of the intervention consists of training 8 Peer Leaders to recruit and lead a Peer Network Intervention among 400 crack users to change norms supporting HIV protective behaviors. The intervention will include monthly meetings open to crack using and non-crack using community residents to reinforce HIV risk reduction skills, and discussion of other topics related to HIV such as illicit drug use and interpersonal violence and community-wide HIV awareness events. Our hypothesis is that these two intervention features will singly, and in combination, reduce HIV risk behaviors among Salvadoran crack users.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

4382

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years or older
  • used crack cocaine in the last 2 weeks

Exclusion Criteria:

  • not giving informed consent
  • under 18 years of age
  • considered by research staff to be unfit or unable to give informed consent
  • engages in continued disruptive behavior while participating in the project
  • not using crack or cocaine in the last month

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: NON_RANDOMIZED
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Social Network HIV Testing
Participants in this arm will be recruited through social networks and will receive an HIV test.
Behavioral: Social Network HIV Testing
Crack users will be recruited for HIV testing and receive 3 coupons to recruit other crack users for HIV testing.
EXPERIMENTAL: Peer Network Intervention
Eight (8) current or former crack users will be recruited to facilitate small networks of crack users in a three-day intervention. They will also facilitate monthly meetings open to all community members regarding HIV prevention and interpersonal violence.
Behavioral: Peer Network Intervention
Peer leaders will recruit small networks of crack users and facilitate a three-day prevention intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Increased HIV testing rates among crack users
Time Frame: 24 months
24 months
Decreased number of sexual risk behaviors among crack users
Time Frame: 12 months
12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Community and organizational factors associated with successful implementation of multi-level, community-based HIV prevention intervention
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Medical College of Wisconsin

Collaborators

National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Julia B. Dickson-Gomez, Ph.D., Medical College of Wisconsin
  • Study Director: Gloria Bodnar, Ph.D., Fundacion Antidrogas de El Salvador (FUNDASALVA)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2010

Primary Completion (ACTUAL)

June 1, 2016

Study Completion (ACTUAL)

December 1, 2020

Study Registration Dates

First Submitted

January 17, 2011

First Submitted That Met QC Criteria

January 18, 2011

First Posted (ESTIMATE)

January 19, 2011

Study Record Updates

Last Update Posted (ACTUAL)

May 14, 2021

Last Update Submitted That Met QC Criteria

May 12, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PRO00013931
  • R01DA020350 (NIH)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sexually Transmitted Diseases

Clinical Trials on Social Network HIV Testing

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe